glow medical aesthetics ltd Company Information
Company Number
05908321
Website
http://medicetics.comRegistered Address
medicetics 37 connaught street, hyde park, london, W2 2AZ
Industry
Specialist medical practice activities
Telephone
02074022033
Next Accounts Due
May 2025
Group Structure
View All
Directors
Vicky Dondos18 Years
Shareholders
geoffrey patrick jude mullan 50%
dr vicky dondos 50%
glow medical aesthetics ltd Estimated Valuation
Pomanda estimates the enterprise value of GLOW MEDICAL AESTHETICS LTD at £269.2k based on a Turnover of £452.3k and 0.6x industry multiple (adjusted for size and gross margin).
glow medical aesthetics ltd Estimated Valuation
Pomanda estimates the enterprise value of GLOW MEDICAL AESTHETICS LTD at £554.7k based on an EBITDA of £122.8k and a 4.52x industry multiple (adjusted for size and gross margin).
glow medical aesthetics ltd Estimated Valuation
Pomanda estimates the enterprise value of GLOW MEDICAL AESTHETICS LTD at £13.9k based on Net Assets of £36k and 0.39x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Glow Medical Aesthetics Ltd Overview
Glow Medical Aesthetics Ltd is a live company located in london, W2 2AZ with a Companies House number of 05908321. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in August 2006, it's largest shareholder is geoffrey patrick jude mullan with a 50% stake. Glow Medical Aesthetics Ltd is a established, micro sized company, Pomanda has estimated its turnover at £452.3k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Glow Medical Aesthetics Ltd Health Check
Pomanda's financial health check has awarded Glow Medical Aesthetics Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
4 Regular
5 Weak
Size
annual sales of £452.3k, make it in line with the average company (£387.2k)
- Glow Medical Aesthetics Ltd
£387.2k - Industry AVG
Growth
3 year (CAGR) sales growth of -13%, show it is growing at a slower rate (4.9%)
- Glow Medical Aesthetics Ltd
4.9% - Industry AVG
Production
with a gross margin of 55.3%, this company has a comparable cost of product (55.3%)
- Glow Medical Aesthetics Ltd
55.3% - Industry AVG
Profitability
an operating margin of 17.6% make it more profitable than the average company (13.2%)
- Glow Medical Aesthetics Ltd
13.2% - Industry AVG
Employees
with 10 employees, this is similar to the industry average (9)
10 - Glow Medical Aesthetics Ltd
9 - Industry AVG
Pay Structure
on an average salary of £30k, the company has an equivalent pay structure (£30k)
- Glow Medical Aesthetics Ltd
£30k - Industry AVG
Efficiency
resulting in sales per employee of £45.2k, this is less efficient (£70.1k)
- Glow Medical Aesthetics Ltd
£70.1k - Industry AVG
Debtor Days
it gets paid by customers after 21 days, this is earlier than average (34 days)
- Glow Medical Aesthetics Ltd
34 days - Industry AVG
Creditor Days
its suppliers are paid after 81 days, this is slower than average (45 days)
- Glow Medical Aesthetics Ltd
45 days - Industry AVG
Stock Days
it holds stock equivalent to 137 days, this is more than average (14 days)
- Glow Medical Aesthetics Ltd
14 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 11 weeks, this is less cash available to meet short term requirements (79 weeks)
11 weeks - Glow Medical Aesthetics Ltd
79 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 95.2%, this is a higher level of debt than the average (31.6%)
95.2% - Glow Medical Aesthetics Ltd
31.6% - Industry AVG
GLOW MEDICAL AESTHETICS LTD financials
Glow Medical Aesthetics Ltd's latest turnover from August 2023 is estimated at £452.3 thousand and the company has net assets of £36 thousand. According to their latest financial statements, Glow Medical Aesthetics Ltd has 10 employees and maintains cash reserves of £87.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 10 | 10 | 10 | 12 | 12 | 12 | 9 | 9 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 187,247 | 133,821 | 153,800 | 166,541 | 132,853 | 153,645 | 173,465 | 175,254 | 172,593 | 190,964 | 210,051 | 149,104 | 167,114 | 155,592 | 166,305 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 878 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 37,032 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 187,247 | 133,821 | 153,800 | 166,541 | 169,885 | 154,523 | 173,465 | 175,254 | 172,593 | 190,964 | 210,051 | 149,104 | 167,114 | 155,592 | 166,305 |
Stock & work in progress | 76,356 | 62,536 | 50,019 | 41,414 | 32,160 | 7,500 | 7,500 | 7,500 | 7,499 | 6,665 | 3,725 | 2,000 | 3,000 | 950 | 700 |
Trade Debtors | 27,128 | 4,254 | 39,423 | 59,529 | 13,551 | 0 | 0 | 0 | 85,561 | 17,839 | 18,018 | 17,418 | 25,435 | 21,148 | 21,663 |
Group Debtors | 28,243 | 171,274 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 337,732 | 356,493 | 63,675 | 49,865 | 73,766 | 95,314 | 75,940 | 74,539 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 87,395 | 211,760 | 506,997 | 418,192 | 120,906 | 100,846 | 78,036 | 63,360 | 33,510 | 16,131 | 24,193 | 25,849 | 71,792 | 45,138 | 43,290 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 556,854 | 806,317 | 660,114 | 569,000 | 240,383 | 203,660 | 161,476 | 145,399 | 126,570 | 40,635 | 45,936 | 45,267 | 100,227 | 67,236 | 65,653 |
total assets | 744,101 | 940,138 | 813,914 | 735,541 | 410,268 | 358,183 | 334,941 | 320,653 | 299,163 | 231,599 | 255,987 | 194,371 | 267,341 | 222,828 | 231,958 |
Bank overdraft | 151,166 | 141,183 | 113,613 | 8,800 | 2,328 | 29,424 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 33,416 | 16,261 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 45,134 | 174,496 | 37,094 | 56,308 | 51,896 | 65,109 | 70,197 | 46,747 | 165,556 | 119,569 | 156,220 | 106,034 | 110,049 | 81,566 | 67,155 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 1,592 | 13,100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 201,014 | 256,163 | 150,899 | 285,709 | 178,684 | 184,128 | 148,272 | 183,560 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 397,314 | 571,842 | 301,606 | 350,817 | 232,908 | 278,661 | 253,477 | 259,668 | 165,556 | 119,569 | 156,220 | 106,034 | 110,049 | 81,566 | 67,155 |
loans | 185,334 | 338,427 | 473,887 | 191,200 | 0 | 0 | 26,479 | 4,291 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,176 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 78,634 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36,921 | 38,423 | 53,895 | 64,994 | 79,049 | 93,137 | 108,073 |
provisions | 46,812 | 25,392 | 0 | 0 | 0 | 0 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 310,780 | 363,819 | 473,887 | 191,200 | 0 | 0 | 26,567 | 7,467 | 36,921 | 38,423 | 53,895 | 64,994 | 79,049 | 93,137 | 108,073 |
total liabilities | 708,094 | 935,661 | 775,493 | 542,017 | 232,908 | 278,661 | 280,044 | 267,135 | 202,477 | 157,992 | 210,115 | 171,028 | 189,098 | 174,703 | 175,228 |
net assets | 36,007 | 4,477 | 38,421 | 193,524 | 177,360 | 79,522 | 54,897 | 53,518 | 96,686 | 73,607 | 45,872 | 23,343 | 78,243 | 48,125 | 56,730 |
total shareholders funds | 36,007 | 4,477 | 38,421 | 193,524 | 177,360 | 79,522 | 54,897 | 53,518 | 96,686 | 73,607 | 45,872 | 23,343 | 78,243 | 48,125 | 56,730 |
Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 43,368 | 25,583 | 25,554 | 24,434 | 21,181 | 21,960 | 22,996 | 17,995 | 20,267 | 20,022 | 22,707 | 20,171 | 19,632 | 17,219 | 17,438 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | |||||||||||||||
Stock | 13,820 | 12,517 | 8,605 | 9,254 | 24,660 | 0 | 0 | 1 | 834 | 2,940 | 1,725 | -1,000 | 2,050 | 250 | 700 |
Debtors | -138,918 | 428,923 | -6,296 | -14,955 | 29,035 | 19,374 | 1,401 | -11,022 | 67,722 | -179 | 600 | -8,017 | 4,287 | -515 | 21,663 |
Creditors | -129,362 | 137,402 | -19,214 | 4,412 | -13,213 | -5,088 | 23,450 | -118,809 | 45,987 | -36,651 | 50,186 | -4,015 | 28,483 | 14,411 | 67,155 |
Accruals and Deferred Income | -55,149 | 105,264 | -134,810 | 107,025 | -5,444 | 35,856 | -35,288 | 183,560 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 21,420 | 25,392 | 0 | 0 | 0 | -88 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | -878 | 878 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | -33,416 | 17,155 | 16,261 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -153,093 | -135,460 | 282,687 | 191,200 | 0 | -26,479 | 22,188 | 4,291 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | -1,592 | -14,684 | 16,276 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 78,634 | 0 | 0 | 0 | 0 | 0 | 0 | -36,921 | -1,502 | -15,472 | -11,099 | -14,055 | -14,088 | -14,936 | 108,073 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -124,365 | -295,237 | 88,805 | 297,286 | 20,060 | 22,810 | 14,676 | 29,850 | 17,379 | -8,062 | -1,656 | -45,943 | 26,654 | 1,848 | 43,290 |
overdraft | 9,983 | 27,570 | 104,813 | 6,472 | -27,096 | 29,424 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -134,348 | -322,807 | -16,008 | 290,814 | 47,156 | -6,614 | 14,676 | 29,850 | 17,379 | -8,062 | -1,656 | -45,943 | 26,654 | 1,848 | 43,290 |
glow medical aesthetics ltd Credit Report and Business Information
Glow Medical Aesthetics Ltd Competitor Analysis
Perform a competitor analysis for glow medical aesthetics ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in W 2 area or any other competitors across 12 key performance metrics.
glow medical aesthetics ltd Ownership
GLOW MEDICAL AESTHETICS LTD group structure
Glow Medical Aesthetics Ltd has no subsidiary companies.
Ultimate parent company
GLOW MEDICAL AESTHETICS LTD
05908321
glow medical aesthetics ltd directors
Glow Medical Aesthetics Ltd currently has 1 director, Dr Vicky Dondos serving since Aug 2006.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Vicky Dondos | 50 years | Aug 2006 | - | Director |
P&L
August 2023turnover
452.3k
+6%
operating profit
79.4k
0%
gross margin
55.4%
-4.66%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2023net assets
36k
+7.04%
total assets
744.1k
-0.21%
cash
87.4k
-0.59%
net assets
Total assets minus all liabilities
Similar Companies
glow medical aesthetics ltd company details
company number
05908321
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
August 2006
age
18
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
swank london ltd (September 2006)
last accounts submitted
August 2023
address
medicetics 37 connaught street, hyde park, london, W2 2AZ
accountant
-
auditor
-
glow medical aesthetics ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to glow medical aesthetics ltd. Currently there are 0 open charges and 1 have been satisfied in the past.
glow medical aesthetics ltd Companies House Filings - See Documents
date | description | view/download |
---|